Early vs late administration of icatibant in patients with hereditary angioedema

被引:0
|
作者
Zanichelli, A. [1 ]
Maurer, M. [2 ]
Aberer, W. [3 ]
Caballero, T. [4 ]
Bouillet, L. [5 ]
Bygum, A. [6 ]
Grumach, A. S. [7 ]
Botha, J. [8 ]
Andresen, I [8 ]
Longhurst, H. J. [9 ]
机构
[1] Univ Milan, Luigi Sacco Hosp, Milan, Italy
[2] Charite Univ Med Berlin, Berlin, Germany
[3] Med Univ Graz, Graz, Austria
[4] Hosp La Paz Inst Hlth Res IdiPaz, Biomed Res Network Rare Dis CIBERER U754, Madrid, Spain
[5] Grenoble Univ Hosp, Grenoble, France
[6] Odense Univ Hosp, Odense, Denmark
[7] Fac Med ABC, Sao Paulo, Brazil
[8] Shire, Zug, Switzerland
[9] Barts Hlth NHS Trust, London, England
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
1427
引用
收藏
页码:721 / 722
页数:2
相关论文
共 50 条
  • [1] Early Versus Late Administration of Icatibant in Patients With Hereditary Angioedema
    Zanichelli, A.
    Maurer, M.
    Aberer, W.
    Caballero, T.
    Bouillet, L.
    Bygum, A.
    Grumach, A. S.
    Botha, J.
    Andresen, I
    Longhurst, H. J.
    [J]. SWISS MEDICAL WEEKLY, 2018, 148 : 24S - 24S
  • [2] Early versus late administration of icatibant in patients with hereditary angioedema
    Andresen, I.
    Aberer, W.
    Caballero, T.
    Bouillet, L.
    Longhurst, H. J.
    Zanichelli, A.
    Bygum, A.
    Grumach, A. S.
    Perrin, A.
    Maurer, M.
    [J]. SWISS MEDICAL WEEKLY, 2017, 147 : 55S - 56S
  • [3] Early Versus Late Administration of Icatibant in Patients With Hereditary Angioedema
    Maurer, Marcus
    Aberer, Werner
    Caballero, Teresa
    Bouillet, Laurence
    Longhurst, Hilary J.
    Zanichelli, Andrea
    Bygum, Anette
    Grumach, Anete S.
    Perrin, Amandine
    Andresen, Irmgard
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB233 - AB233
  • [4] Benefits of Early Administration with Icatibant for the Treatment of Hereditary Angioedema Attacks
    Longhurst, Hilary
    Aberer, Werner
    Bouillet, Laurence
    Caballero, Teresa
    Fabien, Vincent
    Kanny, Gisele
    Zanichelli, Andrea
    Maurer, Marcus
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB33 - AB33
  • [5] Clinical experience with icatibant self-administration for patients with hereditary angioedema
    Boccon-Gibod, I
    Massot, C.
    Bouillet, L.
    [J]. ALLERGY, 2011, 66 : 425 - 426
  • [6] ICATIBANT FOR HEREDITARY ANGIOEDEMA
    Gras, Jordi
    [J]. DRUGS OF TODAY, 2009, 45 (12) : 855 - 864
  • [7] MANAGEMENT OF ADULT PATIENTS WITH ICATIBANT IN HEREDITARY ANGIOEDEMA
    Drake, David
    Sultan, Laith
    [J]. EMERGENCY MEDICINE JOURNAL, 2011, 28 (08) : 720 - 721
  • [8] Icatibant for the Treatment of Hereditary Angioedema
    Cole, Sabrina W.
    Lundquist, Lisa M.
    [J]. ANNALS OF PHARMACOTHERAPY, 2013, 47 (01) : 49 - 55
  • [9] Icatibant for the treatment of hereditary angioedema
    Kalra, Neelu
    Craig, Timothy
    [J]. EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (07): : 743 - 750
  • [10] The Icatibant Outcome Survey: 10 years of experience with icatibant for patients with hereditary angioedema
    Maurer, Marcus
    Aberer, Werner
    Caballero, Teresa
    Bouillet, Laurence
    Grumach, Anete S.
    Botha, Jaco
    Andresen, Irmgard
    Longhurst, Hilary J.
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2022, 52 (09): : 1048 - 1058